Persistence Market Research Company
Customize Now Get FREE Sample

Pulmonary Arterial Hypertension Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Global Pulmonary Arterial Hypertension Market by Drug Class (Endothelin Receptor Antagonists, PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, and SGC Stimulators), by Type (Branded and Generics) by Route of Administration (Oral, Intravenous, and Inhalational), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Analysis from 2026 to 2033

ID: PMRREP33199| 250 Pages | 21 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Pulmonary Arterial Hypertension Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
    3. Global Pulmonary Arterial Hypertension Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2020 – 2025
      3. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
        1. Endothelin Receptor Antagonists
        2. PDE-5 Inhibitors
        3. Prostacyclin and Prostacyclin Analogs
        4. SGC Stimulators
      4. Market Attractiveness Analysis: By Drug Class
    4. Global Pulmonary Arterial Hypertension Market Outlook: Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Type, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
        1. Branded
        2. Generics
      4. Market Attractiveness Analysis: Type
    5. Global Pulmonary Arterial Hypertension Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
        1. Oral
        2. Intravenous
        3. Inhalational
      4. Market Attractiveness Analysis: Route of Administration
    6. Global Pulmonary Arterial Hypertension Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Pulmonary Arterial Hypertension Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  7. Europe Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. East Asia Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis   and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. Latin America Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Middle East & Africa Pulmonary Arterial Hypertension Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Type
      4. By Route of Administration
      5. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis  and Forecast, By Drug Class, 2026 – 2033
      1. Endothelin Receptor Antagonists
      2. PDE-5 Inhibitors
      3. Prostacyclin and Prostacyclin Analogs
      4. SGC Stimulators
    5. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 – 2033
      1. Branded
      2. Generics
    6. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Intravenous
      3. Inhalational
    7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details – Overview, Recent Developments)
      1. United Therapeutics Corporation
        1. Overview
        2. Segments and Drug Class & Distribution Channel
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Bayer AG
      3. Gilead Sciences, Inc.
      4. Merck & Co., Inc.
      5. Pfizer Inc.
      6. Johnson & Johnson
      7. Viatris Inc.
      8. GSK Plc.
      9. Sandoz Group AG
      10. Lupin Pharmaceuticals, Inc.
      11. Sun Pharmaceutical Industries Ltd
      12. Teva Pharmaceutical Industries Ltd
      13. Shubham Pharmachem Pvt Ltd
      14. Arena Pharmaceuticals
      15. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate